Screener
Jazz Pharmaceuticals JAZZ Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Revenues: | ||
| Product sales, net | $1,025.3 | $839.4 |
| Royalties and contract revenues | 43.6 | 58.4 |
| Total revenues | 1,068.9 | 897.8 |
| Operating expenses: | ||
| Cost of product sales (excluding amortization of acquired developed technologies) | 134.1 | 104.6 |
| Selling, general and administrative | 352.7 | 514.0 |
| Research and development | 196.0 | 180.7 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's total revenue?
- Jazz Pharmaceuticals (JAZZ) reported total revenue of $1.07B in Q1 2026.
- How has Jazz Pharmaceuticals's total revenue changed year-over-year?
- Jazz Pharmaceuticals's total revenue increased by 19.1% year-over-year, from $897.8M to $1.07B.
- What is the long-term trend for Jazz Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's total revenue has grown at a 8.4% compound annual growth rate (CAGR), from $3.09B to $4.27B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Jazz Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude